Merus to Report First Quarter 2017 Financial & Mid-Year

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
105
Merus to Report First Quarter 2017 Financial & Mid-Year Operating Results on July 11, 2017

UTRECHT, The Netherlands, July 06, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the company will provide an mid-year update on recent operating progress and report its first quarter 2017 financial results on July 11, 2017. Management will host a conference call and webcast at 4:30 pm ET.

To participate in the call, please dial (646) 722-4972 (domestic) or (866) 978-9968 (international) and reference conference ID 98331903. A live webcast will be available on the Investors page of the Company's website, http://www.merus.nl . An archived presentation will be available for 90 days.

About Merus N.V. Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics® are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have several of the same features of conventional monoclonal antibodies, such as long half-life and low immunogenicity. Merus' lead bispecific antibody candidate, MCLA-128, is expected to begin a Phase 2 clinical trial in the second half of 2017 in two metastatic breast cancer populations. MCLA-128 is also being evaluated in a Phase 1/2 clinical trial in Europe in gastric, ovarian, endometrial and non-small cell lung cancers. Merus' second bispecific antibody candidate, MCLA-117, is being developed in a Phase 1 clinical trial in patients with acute myeloid leukemia. The Company also has a pipeline of proprietary bispecific antibody candidates in preclinical development, including MCLA-158, which is designed to bind to cancer stem cells and is being developed as a potential treatment for colorectal cancer and other solid tumors, as well as MCLA-145 designed to bind to PD-L1 and a non-disclosed second immunomodulatory target, which is being developed in collaboration with Incyte.

Contacts: Media: Eliza Schleifstein +1 973 361 1546 eliza@argotpartners.com Investors: Kimberly Minarovich +1 646 368 8014 kimberly@argotpartners.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 4

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
WellLink Advisory Board Eyes Future of Healthcare Innovation

Updated Category News Views 5

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 2

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 6

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 5

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 5

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 0

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Goddess Maintenance Co. Eyes BeautyMatter Award

Updated Category News Views 4

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

Continue Reading
Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 3

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 9

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading

Top 5 Most Recently Viewed Articles

New Advances in Alzheimer’s Treatment by Nexalin Technology

Updated Category News Views 130

Nexalin Technology's Breakthrough in Alzheimer's Treatment Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) is at the forefront of innovation in the realm of neurostimulation. The company's recent clinical study highlights significant advancements concerning its Gen-2 SYNC device, which employs Deep Intracranial Frequency Stimulation (DIFS™) to treat Alzheimer’s Disease...

Continue Reading
Marcus Corporation Achieves Historic Stock Milestone at $16.17

Updated Category News Views 236

Remarkable Rise in Marcus Corporation Stock Marcus Corporation (MCS) has recently made headlines as its stock surged to a remarkable 52-week high, now standing at $16.17. This achievement is a clear indication of increasing investor confidence and is a significant event in the company’s journey over the last year. The increase is not just a number; it's a reflection of...

Continue Reading
Florida Governor Fuels Cancer Treatment Advancements with $2M Grant

Updated Category News Views 266

Important Investment in Cancer Treatment Technology Recently, the Governor announced a significant $2 million investment aimed at enhancing the accessibility of cutting-edge cancer treatment technologies developed by the esteemed team of researchers at Florida International University (FIU). This funding, originating from the Casey DeSantis Florida Cancer Innovation Fund,...

Continue Reading
Understanding the Elanco Class Action Lawsuit: What Investors Need

Updated Category News Views 261

Understanding the Elanco Class Action Lawsuit Elanco Animal Health Incorporated, known for its dedication to animal welfare and health, is currently the subject of a class action securities lawsuit. This important legal event serves as a reminder for all investors to remain vigilant and informed on matters affecting their investments. Investor Notification and Case...

Continue Reading
Chamber Cardio Secures Funding to Transform Cardiac Care

Updated Category News Views 118

Chamber Cardio Secures Significant Funding to Boost Care Chamber Cardio has successfully raised an impressive $60 million in Series A funding, which will play a crucial role in enhancing value-based care for cardiologists and health plans. This financial round was led by the esteemed Frist Cressey Ventures and saw participation from prominent investors, including General...

Continue Reading